Entrada Therapeutics, Inc. · NASDAQ:TRDA
Entrada Therapeutics, Inc. shareholders
As of Jun 30, 2026, 125 institutions reported holding Entrada Therapeutics, Inc., 75.6% of its shares. Largest: Baker Bros. Advisors LP, 5AM Venture Management, LLC and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Entrada Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 5.07M | 13.0% | no change | Aug 14, 2026 |
| 5AM Venture Management, LLC | 4.06M | 10.4% | no change | Aug 14, 2026 |
| BlackRock | 2.58M | 6.6% | +225K | Aug 7, 2026 |
| Merck & Co., Inc. | 1.74M | 4.5% | new | Aug 7, 2026 |
| Vanguard | 1.7M | 4.4% | +48,456 | Aug 13, 2026 |
| Mpm Bioimpact LLC | 1.25M | 3.2% | new | Aug 14, 2026 |
| TCG Crossover Management, LLC | 1.06M | 2.7% | −1.23M | Aug 14, 2026 |
| Wellington | 954K | 2.5% | −80,363 | Aug 14, 2026 |
| Millennium | 764K | 2.0% | +245K | Aug 14, 2026 |
| StepStone Group LP | 761K | 2.0% | no change | Aug 13, 2026 |